NCT Number: NCT00394862
Efficacy of Weekly Versus Daily Folic Acid Supplementation
Investigate the efficacy of weekly versus daily of folic acid supplementation on improving folate, vitamin B12,
Looking for future studies?
Notify MeKey information
Conditions
Age range
15 year–49 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
460 women of a rural community in the western highlands of Guatemala were recruited for participation in the double-blinded study led by Emory University and the Institute of Nutrition of Central America and Panama (INCAP). The women were randomly assigned one of 4 vitamin treatments containing different levels of folic acid, Vitamin B12, iron and zinc. The treatments were as follows:
- weekly dose of folic acid at 5000ug, iron at 120 mg, zinc at 30mg, and B12 at 16.8 ug;
- weekly dose of folic acid at 2800ug, iron at 120mg, zinc at 0mg and B12 at 16.8ug;
- daily dose of folic acid at 400ug, iron at 60mg, zinc at 15mg, B12 at 2.4ug; and
- daily dose of folic acid at 200ug, iron at 50mg, zinc at 0mg, and B12 at 2.4ug.
The women, aged 15-49, received the vitamins daily for 3 months. Anthropometric data and blood samples were taken at baseline and post-supplementation. The participants also completed a series of dietary interviews at baseline and post-intervention. No pregnant or lactating mothers were admitted into the study, nor severely anemic females. Blood samples were sent to the National Laboratory in Cuernavaca, Mexico, for analysis of serum folate levels.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- female
- aged 15-49
Exclusion criteria
- pregnant
- lactating less than 3 months
- severely anemic
Treatment and study plan
Primary outcomes
-
serum folate level
-
red blood cell folate
Secondary outcomes
-
homocysteine
-
ferritin
-
serum zinc
-
serum B12
-
blood pressure
-
depression
Sponsors and collaborators
Lead sponsor
Emory University
Other
Collaborators
- Centers for Disease Control and Prevention
Registry information
Important dates
- Study start
- 2006
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Nov 1, 2006
- Registry last updated
- Apr 2, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels
NCT06904612
Abnormalities, Severe Teratoid, Anemia
Orlando, Florida, United States
View Trial DetailsMinimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
NCT03936322
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Rochester, Minnesota, United States
View Trial DetailsBirth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
NCT05883761
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lubombo, Lubombo Region, Eswatini
View Trial DetailsSalt-FA to Increase Folate Levels
NCT06174883
Anencephaly-Spina Bifida, Avitaminosis
Orlando, Florida, United States
View Trial Details